ELI LILLY AND COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 923.71 USD | -1.21% |
|
+2.33% | +58.46% |
| 09-13 | Eli Lilly Gets FDA Approval for Eczema Treatment Ebglyss | DJ |
| 09-13 | Eli Lilly Gets US FDA Approval for Atopic Dermatitis Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ELI LILLY AND COMPANY | Other Pharmaceuticals | -1.21% | +2.33% | +58.46% | +54.24% | +733.00% | 832B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LLY Stock
- Charts Eli Lilly and Company
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition